IBX 4.35% 4.8¢ imagion biosystems limited

Ann: First-in-human study update - First patient enrolled, page-354

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 198 Posts.
    lightbulb Created with Sketch. 164
    You are correct. They have built 4 Magsense instruments and all are being used in small animal studies for the various cancers in the pipeline. They are adequate for the trial we are currently in. Design for the human sized Magsense is complete and will commence assembly and completion after this trial is satisfactory and concluded. It will be needed for the pivotal study to follow. And yes, the video posted will answer all them questions, that is why I made it. GLTA!
 
watchlist Created with Sketch. Add IBX (ASX) to my watchlist
(20min delay)
Last
4.8¢
Change
0.002(4.35%)
Mkt cap ! $2.065M
Open High Low Value Volume
4.5¢ 4.8¢ 4.5¢ $7.822K 164.4K

Buyers (Bids)

No. Vol. Price($)
2 69259 4.5¢
 

Sellers (Offers)

Price($) Vol. No.
4.8¢ 31838 1
View Market Depth
Last trade - 16.10pm 15/11/2024 (20 minute delay) ?
IBX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.